Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats

276Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

Abstract

Background - Suppression of tumor growth by thrombospondin-1 (TSP-1) has been associated with its ability to inhibit neovascularization. The antiangiogenic activity of TSP-1, as defined by cornea pocket assays, was previously mapped to the amino-terminal portion of the protein within the procollagen region and the type 1 repeats. Methods and Results - We evaluated the specificity and efficacy of different regions of TSP-1 using recombinant fragments of the protein on chorioallantoic membrane (CAM) angiogenesis and endothelial cell proliferation assays. In both assays, fragments containing the second and third type 1 repeats but not the procollagen region inhibited angiogenesis and endothelial cell proliferation. To further define the sequences responsible for the angiostatic effect of TSP-1, we used synthetic peptides. The CAM assay defined 2 sequences that independently suppressed angiogenesis. The amino-terminal end of the type 1 repeats showed higher potency for inhibiting angiogenesis driven by basic fibroblast growth factor (FGF-2), whereas the second region equally blocked angiogenesis driven by either FGF-2 or vascular endothelial growth factor (VEGF). Modifications of the active peptides revealed the specific amino acids required for the inhibitory response. One sequence included the conserved tryptophan residues in the amino-terminal end of the second and third type 1 repeats, and the other involved the amino acids that follow the CSVTCG sequence in the carboxy-terminus of these repeats. Both inhibition in the CAM assay and inhibition of breast tumor xenograft growth in nude mice were independent of the TGF-β-activating sequence located in the second type 1 repeat. Conclusions - These results indicate that the type 1 repeats of TSP-1 contain 2 subdomains that may independently inhibit neovascularization. They also identify 2 independent pathways by which TSP-1 can block FGF-2 and VEGF angiogenic signals on endothelial cells.

Author supplied keywords

References Powered by Scopus

Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

2605Citations
N/AReaders
Get full text

Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1

605Citations
N/AReaders
Get full text

CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells

585Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The ADMTS metalloproteinases

656Citations
N/AReaders
Get full text

FGF/FGFR signaling in health and disease

506Citations
N/AReaders
Get full text

Endogenous inhibitors of angiogenesis

486Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Iruela-Arispe, M. L., Lombardo, M., Krutzsch, H. C., Lawler, J., & Roberts, D. D. (1999). Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation, 100(13), 1423–1431. https://doi.org/10.1161/01.CIR.100.13.1423

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 42

66%

Professor / Associate Prof. 12

19%

Researcher 9

14%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 26

41%

Biochemistry, Genetics and Molecular Bi... 26

41%

Medicine and Dentistry 9

14%

Engineering 3

5%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free